This is the authors' abstract. We don't add key points for this paper.
The wide spectrum of risk associated with chronic kidney disease (CKD) is a fundamental challenge in delivering timely, high quality CKD care. Although many patients with CKD experience stable long-term kidney function, others experience rapid decline in kidney function and progression toward kidney failure along with other risks associated with advanced CKD (eg, cardiovascular disease).1 Complications in progressive CKD have substantial implications for costs of care: Medicare expenditures per beneficiary with CKD G4/G5 are 40% higher than those per beneficiary with CKD G3.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: